Diluted EPS came in at $-0.79, missed the $-0.70 consensus by $0.09.
Trailing eight quarters through Q4 2024
Common questions about Replimune Group's Q4 2024 earnings report.
Replimune Group (REPL) reported Q4 2024 earnings on February 12, 2025 before market open.
Replimune Group reported diluted EPS of $-0.79 for Q4 2024.
EPS missed the consensus estimate of $-0.70 by $0.09.
You can read the 10-Q periodic report (0001737953-25-000004) directly on SEC EDGAR. The filing index links above go to sec.gov.